NATIONAL BLOOD NETWORK

Forms and Documents

Document	Type	Status	Availability

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Collection	Type	Status	Form
139969	NATIONAL BLOOD NETWORK	Form	Migrated

ICR Details

OMB Control No: 2070-0087	ICR Reference No: 198609-2070-006
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: EPA/OCSPP	Agency Tracking No:
Title: NATIONAL BLOOD NETWORK
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 12/16/1986
	Date Received in OIRA: 09/19/1986
Terms of Clearance: Since the blood analysis contemplated in the National Blood Netword cannot be readily incorporated into HHS's NHANE study, OMB is approvin the NBN for two years to allow EPA to conduct the pilot study and gain one year of field experience. In the two year time period EPA must answer the following questions about the practical utility of the NBN: (1) how does combining individual blood samples affect EPA's ability t track routes of exposure? (2) how does the blood donor population compare to the general population? and (3) can EPA translate chemical concentrations in blood to estimates of health risks? If the two year study demonstrates that the blood analysis contemplated by the NBN is feasible, EPA should again consult with HHS in order to incorporate the NBN analysis into NHANES. NHANES is preferable to the NBN because NHANES provides for a representative nationwide sample and collects a significant amount of background information on the study participants This will allow EPA and HHS to better trace routes of exposure. If EPA resubmits the NBN for approval it must document the practical effects of the NBN information on the Agency's priorities. For exampl how would the NBN help the Agency better target its resources to chemicals of concern. In addition, should answer whether the NBN can be substituted for the human adipose tissue survey and/or perform the surveys on alternate years.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	11/30/1988	11/30/1988
Responses	4,500	0	0
Time Burden (Hours)	1,500	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: TO IDENTIFY THE PREVALENCES AND LEVELS OF TOXIC SUBSTANCES IN HUMAN BLOOD TO SUPPORT OTS' TEST RULES AND EXISTING CHEMICALS ASSESSMENT PROGRAMS. ALSO BASELINE AND TREND INFORMATION ON THESE COMPOUNDS WILL BE DEVELOPED FOR THE GENERAL POPULATION AND SELECTED DEMOGRAPHIC AND GEOGRAPHIC SUBPOPULATIONS.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
NATIONAL BLOOD NETWORK	1201

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	4,500	0	0	4,500	0	0
Annual Time Burden (Hours)	1,500	0	0	1,500	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 09/19/1986

---